ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
208.56
-5.73 (-2.67%)
At close: Jul 30, 2026, 4:00 PM EDT
209.15
+0.59 (0.28%)
Pre-market: Jul 31, 2026, 4:02 AM EDT
ResMed Revenue
ResMed had revenue of $1.43B in the quarter ending March 31, 2026, with 10.81% growth. This brings the company's revenue in the last twelve months to $5.54B, up 10.28% year-over-year. In the fiscal year ending June 30, 2025, ResMed had annual revenue of $5.15B with 9.84% growth.
Revenue (ttm)
$5.54B
Revenue Growth
+10.28%
P/S Ratio
5.43
Revenue / Employee
$554,889
Employees
9,980
Market Cap
30.08B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 5.15B | 461.03M | 9.84% |
| Jun 30, 2024 | 4.69B | 462.30M | 10.95% |
| Jun 30, 2023 | 4.22B | 644.87M | 18.02% |
| Jun 30, 2022 | 3.58B | 381.30M | 11.93% |
| Jun 30, 2021 | 3.20B | 239.81M | 8.11% |
| Jun 30, 2020 | 2.96B | 350.44M | 13.44% |
| Jun 30, 2019 | 2.61B | 266.38M | 11.38% |
| Jun 30, 2018 | 2.34B | 273.46M | 13.23% |
| Jun 30, 2017 | 2.07B | 228.02M | 12.40% |
| Jun 30, 2016 | 1.84B | 159.80M | 9.52% |
| Jun 30, 2015 | 1.68B | 123.94M | 7.97% |
| Jun 30, 2014 | 1.55B | 40.52M | 2.68% |
| Jun 30, 2013 | 1.51B | 145.94M | 10.66% |
| Jun 30, 2012 | 1.37B | 125.37M | 10.08% |
| Jun 30, 2011 | 1.24B | 150.79M | 13.80% |
| Jun 30, 2010 | 1.09B | 171.62M | 18.64% |
| Jun 30, 2009 | 920.74M | 85.34M | 10.22% |
| Jun 30, 2008 | 835.40M | 119.07M | 16.62% |
| Jun 30, 2007 | 716.33M | 109.34M | 18.01% |
| Jun 30, 2006 | 607.00M | 181.49M | 42.65% |
| Jun 30, 2005 | 425.51M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medline | 29.14B |
| Becton, Dickinson and Company | 22.23B |
| Baxter International | 11.47B |
| Alcon | 10.63B |
| Solventum | 8.26B |
| Avantor | 6.56B |
| The Cooper Companies | 4.23B |
| Align Technology | 4.14B |
RMD News
- 9 days ago - BetterInvesting™ Magazine Update on Broadridge Financial Resources Inc. (NYSE:BR) and ResMed Inc. (NYSE:RMD) - PRNewsWire
- 14 days ago - ResMed downgraded to Sector Perform from Outperform at RBC Capital - TheFly
- 15 days ago - ResMed price target lowered to $220 from $235 at Mizuho - TheFly
- 18 days ago - ResMed downgraded to Neutral from Buy at Citi - TheFly
- 20 days ago - ResMed price target lowered to $225 from $240 at Jefferies - TheFly
- 22 days ago - ResMed price target lowered to $276 from $321 at RBC Capital - TheFly
- 22 days ago - ResMed price target lowered to $225 from $227 at Wells Fargo - TheFly
- 23 days ago - ResMed to sell software business MatrixCare for $490 million - Reuters